EQS-News: Aclarion, Inc. / Key word (s): Financial Aclarion Announces Closing of $14.4 Million Public Offering of Common Stock and Warrants 17.01.2025 / 22:50 CET/CEST The issuer is solely ...

(Nasdaq: ACON), a company specializing in cutting-edge healthcare technology, saw its stock price surge by +6.44%, reaching $0.0479 during Friday’s premarket trading session. The jump follows the ...

In recent trading, Aclarion Inc (ACON) stock price has shown some volatility, fluctuating -67.49% over the last five trades and -57.14% over the past 30 trades. This represents a notable shift from ...

Aclarion, Inc. (ACON) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of ...

Aclarion, Inc. (NASDAQ: ACON) recently disclosed the outcomes of its 2024 Annual Meeting of Stockholders in a Form 8-K filing with the Securities and Exchange Commission. The meeting, which took place ...

Aclarion, Inc. (NASDAQ: ACON) has announced the termination of the At-The-Market Issuance Sales Agreement with Ascendiant Capital Markets, LLC. The termination notice was given on January 3, 2025, and ...

Aclarion, Inc. is a healthcare technology company, which engages in the provision of Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. It utilizes ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side ...

Aclarion, Inc. ("Aclarion" or the "Company") (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help ...

Aclarion, Inc. ("Aclarion" or the "Company") (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help ...